China Neurorehabilitation Devices Market Research Report By Type (Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interfaces), By Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Cerebral Palsy, Schizophrenia) and By End User (Rehabilitation Centers, Hospitals & Clinics, Home Care) -Forecast to 2035
As per Market Research Future analysis, the China Neurorehabilitation Devices Market size was estimated at 65.49 USD Million in 2024. The Neurorehabilitation Devices market is projected to grow from 71.41 USD Million in 2025 to 169.71 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 9.0% during the forecast period 2025 - 2035
The China neurorehabilitation devices market is experiencing robust growth driven by technological advancements and increasing healthcare investments.
| 2024 Market Size | 65.49 (USD Million) |
| 2035 Market Size | 169.71 (USD Million) |
| CAGR (2025 - 2035) | 9.04% |
ReWalk Robotics (IL), Ekso Bionics (US), Medtronic (US), Bionik Laboratories (CA), AlterG (US), NeuroPace (US), Hocoma (CH), Tyromotion (AT), Kessler Foundation (US)
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry
This market is experiencing notable growth, driven by an increasing prevalence of neurological disorders and a rising aging population. The demand for innovative rehabilitation solutions is on the rise, as healthcare providers seek to enhance patient outcomes through advanced technologies. In recent years, there has been a shift towards integrating artificial intelligence and robotics into rehabilitation practices, which appears to improve the efficiency and effectiveness of therapy. Furthermore, government initiatives aimed at promoting healthcare advancements are likely to bolster the development and adoption of these devices. In addition, This market is witnessing a surge in investment from both public and private sectors. This influx of funding is facilitating research and development efforts, leading to the introduction of novel products that cater to diverse patient needs. The focus on personalized rehabilitation solutions is becoming increasingly prominent, as practitioners aim to tailor therapies to individual requirements. Overall, the China Neurorehabilitation Devices Market is evolving, with a strong emphasis on technological innovation and patient-centered care.
The neurorehabilitation devices market is increasingly incorporating advanced technologies such as artificial intelligence and robotics. These innovations are enhancing the precision and effectiveness of rehabilitation therapies, allowing for more tailored treatment plans that cater to individual patient needs.
Government initiatives are playing a crucial role in the growth of the neurorehabilitation devices market. Increased funding and support for healthcare advancements are facilitating research and development, leading to the emergence of new devices that improve patient outcomes.
There is a growing emphasis on personalized rehabilitation solutions within the neurorehabilitation devices market. Healthcare providers are striving to customize therapies to meet the unique requirements of each patient, thereby enhancing the overall effectiveness of rehabilitation efforts.
China's rising healthcare expenditure is a significant driver for the neurorehabilitation devices market. The government has been increasing its investment in healthcare infrastructure, with spending projected to reach 7.5% of GDP by 2025. This financial commitment is likely to enhance the availability of advanced rehabilitation technologies in hospitals and clinics. As healthcare facilities upgrade their equipment, the demand for neurorehabilitation devices is expected to surge. Additionally, the growing awareness of the importance of rehabilitation in recovery processes is prompting healthcare providers to allocate more resources towards these devices. Consequently, the neurorehabilitation devices market is poised for growth as funding and resources become more readily available to support innovative rehabilitation solutions.
The Chinese government is actively promoting policies aimed at enhancing rehabilitation services, which serves as a crucial driver for the neurorehabilitation devices market. Initiatives such as the Healthy China 2030 plan emphasize the importance of rehabilitation in improving public health outcomes. Additionally, funding programs and subsidies are being introduced to support the development and adoption of innovative rehabilitation technologies. These government efforts are likely to stimulate market growth by encouraging manufacturers to invest in research and development of new devices. As a result, the neurorehabilitation devices market is expected to benefit from a favorable regulatory environment and increased support for rehabilitation initiatives.
The increasing prevalence of neurological disorders in China is a primary driver for the neurorehabilitation devices market. Conditions such as stroke, traumatic brain injury, and neurodegenerative diseases are becoming more common, with estimates suggesting that over 7 million individuals in China are affected by stroke alone. This growing patient population necessitates advanced rehabilitation solutions, thereby propelling demand for neurorehabilitation devices. The market is projected to expand as healthcare providers seek effective tools to enhance recovery outcomes. Furthermore, the aging population in China, which is expected to reach 400 million by 2040, further exacerbates the need for innovative rehabilitation technologies. As a result, the neurorehabilitation devices market is likely to witness substantial growth driven by the urgent need to address these health challenges.
There is a growing awareness among healthcare professionals and patients regarding the benefits of neurorehabilitation. Educational initiatives and campaigns are being launched to inform the public about the importance of rehabilitation in recovery from neurological conditions. This heightened awareness is leading to an increase in demand for neurorehabilitation devices, as patients and families seek effective solutions for recovery. Furthermore, healthcare providers are increasingly recognizing the value of early intervention and continuous rehabilitation, which is likely to drive the adoption of advanced devices. As a result, the neurorehabilitation devices market is expected to expand as more individuals seek out these technologies to aid in their recovery journeys.
Technological innovations are significantly influencing the neurorehabilitation devices market. The integration of robotics, artificial intelligence, and virtual reality into rehabilitation practices is transforming patient care. For instance, robotic exoskeletons and smart rehabilitation devices are being developed to provide personalized therapy, enhancing patient engagement and recovery rates. The market for these advanced devices is expected to grow at a CAGR of approximately 15% over the next five years. Moreover, the adoption of tele-rehabilitation solutions is on the rise, allowing patients to receive therapy remotely, which is particularly beneficial in rural areas of China. These advancements not only improve the efficacy of rehabilitation but also expand access to care, thereby driving the growth of the neurorehabilitation devices market.
China Neurorehabilitation Devices Market Segment Insights
Neurorehabilitation Devices Market Type Insights
The China Neurorehabilitation Devices Market is experiencing growth across various types of devices aimed at improving the recovery and rehabilitation process for individuals with neurological disorders. Among the types, Neuro-Robotic Devices are gaining significant attention for their ability to provide assisted movement and enhance functional recovery through robotic exoskeletons and rehabilitation robots.
This technology not only supports motor function but also encourages patient engagement, making rehabilitation more effective. Wearable Devices are also key players in this market, as they offer portable and user-friendly solutions that enable continuous monitoring of patient's progress.By utilizing sensors and mobile applications, they empower patients to take an active role in their rehabilitation.
Non-Invasive Stimulators have emerged as pivotal, utilizing methods such as transcranial magnetic stimulation to stimulate the brain without direct surgery or invasive procedures. This segment is particularly valued for its potential to induce neuroplasticity, aiding in the recovery of lost functions. Additionally, Brain-Computer Interfaces represent a fascinating aspect of the market, allowing direct communication between the brain and external devices to facilitate independence in daily activities.
This technology holds the promise of transforming rehabilitation by enabling patients to control devices through thought alone, making it a significant area of focus for future advancements.
Neurorehabilitation Devices Market Application Insights
The Application segment of the China Neurorehabilitation Devices Market is pivotal, spanning a diverse range of conditions that require rehabilitative care. Brain Stroke remains a leading concern, as it significantly impacts rehabilitation efforts and the need for advanced therapeutic devices. Parkinson's Disease also commands attention due to the rising prevalence in the aging population, driving innovation in neurorehabilitation technologies. Multiple Sclerosis, through its complex nature, has necessitated specialized devices catering to the unique challenges faced by patients.
The segment also addresses Spinal Cord Injury, which requires sophisticated rehabilitation protocols, highlighting the urgent need for effective devices to enhance recovery. Similarly, Cerebral Palsy represents a significant demographic that benefits from tailored neurorehabilitation solutions, underscoring the market’s response to specific patient needs.
Additionally, Schizophrenia management through neurorehabilitation devices is gaining traction, emphasizing a holistic approach to mental and physical health. Overall, the Application segment plays a crucial role in shaping the China Neurorehabilitation Devices Market, driven by the need for therapeutic efficacy and better patient outcomes across these diverse conditions.
Neurorehabilitation Devices Market End User Insights
The China Neurorehabilitation Devices Market, with its diverse applications across various end users, is witnessing significant growth driven by factors such as an increasing elderly population and rising incidences of neurological disorders. Rehabilitation Centers play a crucial role in this market as they focus on providing specialized patient care and therapy, often utilizing advanced neurorehabilitation devices for effective treatment outcomes. Hospitals and Clinics are also key players, offering a range of services that cater to patients requiring acute and long-term neurorehabilitation.
This segment is significant as it often integrates cutting-edge technologies, enhancing rehabilitation effectiveness. Home Care solutions are gaining traction as well, reflecting a shift towards more personalized rehabilitation approaches and allowing patients to recover in familiar environments.
The demand for neurorehabilitation devices in these end-user settings is driven by the need for tailored recovery processes and improved accessibility, ultimately contributing to the market's overall growth trajectory. With ongoing investments in healthcare infrastructure and advancements in technology, the dynamics of the China Neurorehabilitation Devices Market across these segments are expected to evolve substantially in the coming years.
Get more detailed insights about China Neurorehabilitation Devices Market Request Free Sample
The neurorehabilitation devices market in China is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for effective rehabilitation solutions. Key players such as ReWalk Robotics (IL), Ekso Bionics (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. ReWalk Robotics (IL) focuses on innovation in exoskeleton technology, aiming to improve mobility for individuals with spinal cord injuries. Meanwhile, Ekso Bionics (US) emphasizes partnerships with rehabilitation centers to expand its reach and integrate its devices into clinical practices. Medtronic (US) leverages its extensive portfolio in medical devices to incorporate neurorehabilitation solutions, indicating a strategic focus on comprehensive patient care. Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological innovation and collaborative efforts. In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The collective influence of these key players shapes the market structure, fostering an environment where innovation and operational efficiency are paramount. As companies optimize their supply chains and adapt to local market needs, they position themselves to better respond to the evolving demands of healthcare providers and patients alike. In October 2025, ReWalk Robotics (IL) announced a strategic partnership with a leading rehabilitation hospital in Shanghai to pilot its latest exoskeleton model. This collaboration is significant as it not only enhances the company's visibility in the Chinese market but also allows for real-world testing and feedback, potentially leading to further innovations tailored to local needs. Such partnerships are likely to bolster ReWalk's competitive edge by integrating its technology into established rehabilitation practices. In September 2025, Ekso Bionics (US) launched a new version of its EksoGT exoskeleton, which features advanced AI capabilities for personalized rehabilitation. This development underscores the company's commitment to integrating cutting-edge technology into its products, thereby enhancing user experience and outcomes. The introduction of AI-driven features may position Ekso Bionics as a leader in the market, appealing to both healthcare providers and patients seeking effective rehabilitation solutions. In August 2025, Medtronic (US) expanded its neurorehabilitation product line by acquiring a startup specializing in brain-computer interface technology. This acquisition is indicative of Medtronic's strategy to diversify its offerings and enhance its technological capabilities. By integrating brain-computer interfaces with traditional rehabilitation devices, Medtronic could potentially revolutionize the rehabilitation process, making it more efficient and tailored to individual patient needs. As of November 2025, the competitive trends in the neurorehabilitation devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among companies are shaping the landscape, fostering innovation and enhancing product offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to deliver personalized rehabilitation solutions. This shift may redefine how companies position themselves in the market, emphasizing the importance of adaptability and forward-thinking strategies.
Recent developments in the China Neurorehabilitation Devices Market indicate a significant growth trajectory driven by rising demand for advanced technologies in inpatient rehabilitation.
Companies such as NeuroWave, Shenzhen Longteng Medical Technology, and Wuxi Tianyi Medical Equipment are increasingly focusing on Research and Development to innovate their product offerings. In March 2023, Neuroelectrics announced enhancements in their neurostimulation devices, aligning with the growing market focus on non-invasive therapies.
Major players like MicroPort Scientific Corporation and Reha Technology are pursuing strategic partnerships to expand their market footprint. Notably, in July 2023, Hengrong Technology entered a strategic partnership with Bionik Laboratories to co-develop robotic rehabilitation solutions aimed at stroke recovery.
The market is also experiencing a notable shift with an increase in telerehabilitation services, supported by digital health initiatives from the Chinese government, enhancing access to neurorehabilitation devices. Over the last two years, investments in Artificial Intelligence and robotics within the rehabilitation sector have surged, demonstrating the commitment of companies like MindMotion and Intelligent Rehabilitation Technology to leverage technology for improved patient outcomes.
The Neurorehabilitation Devices Market in China is projected to grow at a 9.04% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand.
New opportunities lie in:
By 2035, the market is expected to achieve substantial growth and innovation.
| MARKET SIZE 2024 | 65.49(USD Million) |
| MARKET SIZE 2025 | 71.41(USD Million) |
| MARKET SIZE 2035 | 169.71(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.04% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | ReWalk Robotics (IL), Ekso Bionics (US), Medtronic (US), Bionik Laboratories (CA), AlterG (US), NeuroPace (US), Hocoma (CH), Tyromotion (AT), Kessler Foundation (US) |
| Segments Covered | Type, Application, End-User |
| Key Market Opportunities | Integration of artificial intelligence in neurorehabilitation devices enhances personalized patient care and treatment outcomes. |
| Key Market Dynamics | Technological advancements and regulatory support drive growth in the neurorehabilitation devices market. |
| Countries Covered | China |
The market valuation was $65.49 Million in 2024.
The projected valuation for 2035 is $169.71 Million.
The expected CAGR during this period is 9.04%.
The segments include Neuro-Robotic Devices, Wearable Medical Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces.
The market size for Neuro-Robotic Devices was $15.0 Million in 2024.
The market for Wearable Medical Devices is projected to grow to $50.0 Million by 2035.
Key applications include Brain Stroke, Parkinson's Disease, Multiple Sclerosis, and Spinal Cord Injury.
The market size for hospitals and clinics was $25.0 Million in 2024.
Key players include ReWalk Robotics, Ekso Bionics, Medtronic, and Bionik Laboratories.
The projected market size for Non-Invasive Stimulators is $42.0 Million by 2035.
Kindly complete the form below to receive a free sample of this Report
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
